Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis.

Although DMI treatment of 500 mg/kg and 600 mg/kg slightly reduced cumulative disease score compared to DMI treatment of 400 mg/kg in EAE, the differences did not reach statistical significance (data not shown).

also in 111,027 other papers